PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Internal Medicine10.3904/kjim.2014.29.3.3792014293379Acute esophageal necrosis occurring in a patient undergoing percutaneous coronary interventionHyung-Jin Kwon, Sang-Ho Park, Ji-Hoon Ahn, Tae-Hoon Lee, Chang-Kyun Leehttp://synapse.koreamed.org/pdf/10.3904/kjim.2014.29.3.379, http://synapse.koreamed.org/DOIx.php?id=10.3904/kjim.2014.29.3.379, http://www.kjim.org/upload/kjim-29-3-15_379-382.pdf
Atrial Fibrillation and Percutaneous Coronary Intervention10.1007/978-3-319-42400-2_3201639-58Atrial Fibrillation on Vitamin K Antagonist Undergoing Urgent Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary SyndromeKurt Huberhttp://link.springer.com/content/pdf/10.1007/978-3-319-42400-2_3
Atrial Fibrillation and Percutaneous Coronary Intervention10.1007/978-3-319-42400-2_4201659-77Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Urgent Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary SyndromeUwe Zeymerhttp://link.springer.com/content/pdf/10.1007/978-3-319-42400-2_4
Atrial Fibrillation and Percutaneous Coronary Intervention10.1007/978-3-319-42400-2_6201695-120Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial InfarctionTuomas O. Kiviniemi, K. E. Juhani Airaksinenhttp://link.springer.com/content/pdf/10.1007/978-3-319-42400-2_6
Atrial Fibrillation and Percutaneous Coronary Intervention10.1007/978-3-319-42400-2_5201679-94Atrial Fibrillation on Vitamin K Antagonist Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial InfarctionGiuseppe Gargiulo, Davide Capodannohttp://link.springer.com/content/pdf/10.1007/978-3-319-42400-2_5
Drug Design, Development and Therapy10.2147/dddt.s120562010203Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndromePhuong-Thu Phamhttps://www.dovepress.com/getfile.php?fileID=7613
Vascular Health and Risk Management10.2147/vhrm.s48282009677Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary interventionEllen Keeleyhttps://www.dovepress.com/getfile.php?fileID=5177
Journal of the American College of Cardiology10.1016/j.jacc.2017.07.39320177016C111GW28-e0148 A meta-analysis of bivalirudin compared with unfractionated heparin in patients with acute coronary syndromes undergoing urgent percutaneous coronary intervention versus elective percutaneous coronary interventionYulong Liu, Liang Li, Mei Wanghttps://api.elsevier.com/content/article/PII:S0735109717384012?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0735109717384012?httpAccept=text/plain
Journal of Interventional Cardiology10.1111/joic.121422014275472-481Cardioprotective Effects of Oral Nicorandil Use in Diabetic Patients Undergoing Elective Percutaneous Coronary InterventionMOHAMED SHEHATAhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjoic.12142
Atrial Fibrillation and Percutaneous Coronary Intervention10.1007/978-3-319-42400-2_120161-18Atrial Fibrillation on Vitamin K Antagonist Undergoing Elective Percutaneous Coronary Intervention for Stable Effort AnginaRaffaele Piccolo, Thomas Pilgrim, Stephan Windeckerhttp://link.springer.com/content/pdf/10.1007/978-3-319-42400-2_1